DailyDoctor Archive Specialties Get app
All ophthalmology briefings

The edition · Ophthalmology

Angle closure that is really VKH: the cost of not looking behind the lens

An Indian series shows Vogt-Koyanagi-Harada disease masquerading as angle closure with diagnostic delays of up to seven years, genetics flag a retinal signal for CETP inhibitors, and home tonometry catches pressure burden the clinic misses.

The edition in brief

Among 768 patients with Vogt-Koyanagi-Harada disease at an Indian tertiary centre, 18 (36 eyes) first presented as angle closure; fundus examination was often deferred, diagnosis was delayed by up to seven years, and poorer presenting vision predicted worse outcome. Drug-target Mendelian randomisation in UK Biobank and a Singapore cohort linked genetically proxied CETP inhibition with higher risk of AMD, including roughly threefold odds of exudative AMD and polypoidal choroidal vasculopathy in East Asians - a safety signal to watch as these lipid drugs advance. In 150 treated glaucomatous eyes, home tonometry metrics capturing how far and how often pressure exceeded the patient's target were associated with faster visual field loss, while clinic readings were not. A Korean natural history study of 126 patients with EYS retinal degeneration found linear ellipsoid zone loss of about 4.6% a year. The pearl covers bilateral acute angle closure.

In this edition

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this one is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

Tomorrow morning, before your first patient

One edition a day for ophthalmology, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free